Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_assertion type Assertion NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_head.
- NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_assertion description "[Thus, CDKN2 deletions occur twice as commonly in GBM with EGFR amplification (71%) than in GBM with TP53 mutation (29%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_provenance.
- NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_assertion evidence source_evidence_literature NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_provenance.
- NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_assertion SIO_000772 9217972 NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_provenance.
- NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_assertion wasDerivedFrom gad-20130706 NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_provenance.
- NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_assertion wasGeneratedBy ECO_0000203 NP45186.RA_3j-CYFBsrM1fEpZlNIqnQMpYpCgmreLqhqd14vpiLU130_provenance.